Clinical Trials Browser

Interventional × Acrocephalosyndactylia × lenvatinib × Clear all

NCT02846766 2018-08-02

Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling

Phase 2 Withdrawn

Acrocephalosyndactylia, Neoplasms